🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to evaluate the efficacy and safety of elacestrant, in partic...
Status
Recruiting
Location
Dana Farber Cancer Institute
Start Date
2026-03-25
Trial ID
NCT07467772
Treatments Being Tested
This study is a prospective, single-center, open-label, umbrella-shaped pha...
Status
Unknown
Location
Cancer Hospital Affiliated to Fudan University
Start Date
2020-05-01
Trial ID
NCT04355858
This study is a window of opportunity clinical trial to evaluate the effica...
Status
Completed
Location
Hopital Europeen Georges Pompidou
Start Date
2023-07-20
Trial ID
NCT05659563
Treatments Being Tested
The overall goal is to define and characterize the manometric characteristi...
Status
Recruiting
Location
Medical College of Wisconsin
Start Date
2013-11-01
Trial ID
NCT05696184
Given the uncertain benefit in efficacy of adding CDK 4/6 to first rather t...
Status
Active Not Recruiting
Location
Jeroen Bosch Ziekenhuis
Start Date
2017-11-09
Trial ID
NCT03425838
Treatments Being Tested
This phase 3 clinical trial compares the efficacy and safety of palazestran...
Status
Recruiting
Location
Clinical Trial Site
Start Date
2025-11-03
Trial ID
NCT07085767
Treatments Being Tested
This is a first-in-human, open-label, Phase 1 study evaluating BBI-940, an ...
Status
Terminated
Location
The START Center for Cancer Research
Start Date
2026-02-25
Trial ID
NCT07408089
Treatments Being Tested
The purpose of this study is to visualize and quantify ER-binding sites dur...
Status
Completed
Location
Institut Jules Bordet
Start Date
2016-04-01
Trial ID
NCT02650817
Treatments Being Tested
This is a Phase III open-label study to assess if camizestrant improves out...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-10-05
Trial ID
NCT05952557
Treatments Being Tested
Trial design: Phase II, prospective, multi-center, randomized, open label,...
Status
Recruiting
Location
Vinzenz Von Paul Kliniken gGmbH - Marienhospital
Start Date
2024-12-13
Trial ID
NCT06201234
Treatments Being Tested